Autopsy report · NCT04156399

Acupuncture for Adults With Sickle Cell Disease (SCD): A Feasibility Study

“Due to the Coronavirus Disease 2019 (COVID-19) pandemic”

The sponsor’s own words in the registry.

Life of this trial

• Registered 2 months before it started.
• Ran for about 2 months before it stopped.
• 6 participants enrolled.
• Results were posted on the registry 2 years 1 month after it ended.

Vital statistics

Status

Terminated

Phase

Na

Sponsor

University of Illinois at Chicago

Sponsor type

University, hospital or other

Conditions

Sickle Cell Disease

Interventions

Acupuncture

Participants

6

Sites

1

Countries

United States

Trials that died the same way

• Low Intensity Shockwaves Therapy for the Treatment of Erectile Dysfunction. 12- Month Follow-Up
  “Due to COVID-19 Pandemic” (86% match in meaning)
• Sustaining the Reach of a Scalable Weight Loss Intervention Through Financial Incentives
  “Due to the COVID-19 pandemic” (86% match in meaning)
• Yogurt Supplementation to Alter Bone Biomarkers, the Gut Microbiota and Inflammation in Older Adults
  “Due to the onset of the COVID-19 pandemic” (85% match in meaning)
• Effects of Stoss Therapy of Vitamin D3 on Peri-operative Outcomes in Patients Receiving General Surgery
  “Because of impact from COVID-19 pandemic” (79% match in meaning)
• Prevalence and Impact on QoL From Ototoxicity in Cancer Survivors
  “due to COVID-19” (79% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.